Clinical Director of Imperial College’s Center for Psychedelic Research Joins Entheon Advisory Board

Vancouver, British Columbia–(Newsfile Corp. – August 25, 2021) – Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF)…

Entheon Biomedical Corp. Announces DTC Eligibility

Vancouver, British Columbia–(Newsfile Corp. – August 24, 2021) – Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF)…

Entheon Biomedical Announces Sponsorship of a Clinical Study to Assess the Electroneurophysiologic Effects of Ketamine

Vancouver, British Columbia–(Newsfile Corp. – August 12, 2021) – Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF)…

Entheon Biomedical Corp. Acquires Lobo Genetics Inc.

Vancouver, British Columbia–(Newsfile Corp. – July 30, 2021) – Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF)…

Entheon Biomedical Further Strengthens Advisory Board with Appointment of Dr. Andy Greenshaw

Vancouver, British Columbia–(Newsfile Corp. – July 28, 2021) – Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF)…

Entheon Biomedical Announces Medical Advisor, Dr. Dinesh Bhayana

Vancouver, British Columbia–(Newsfile Corp. – June 30, 2021) – Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF)…

Entheon Subsidiary, HaluGen Life Sciences, Partners with Maya Health to Drive Psychedelics Genetic Test Kit Awareness

Vancouver, British Columbia–(Newsfile Corp. – June 25, 2021) – Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF)…

Entheon Biomedical Subsidiary, HaluGen Life Sciences, Announces Agreement with Third Wave

Vancouver, British Columbia–(Newsfile Corp. – June 22, 2021) – Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF)…

Entheon Biomedical’s Wholly-Owned Subsidiary, HaluGen Life Sciences and Silo Wellness Announces Psychedelics Genetic Test Kit Partnership

Vancouver, British Columbia–(Newsfile Corp. – June 17, 2021) – Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF)…

Entheon Biomedical Corp. Announces Agreement to Acquire Lobo Genetics Inc.

Vancouver, British Columbia–(Newsfile Corp. – June 16, 2021) – Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF)…

Entheon Biomedical’s Wholly-Owned Subsidiary, HaluGen Life Sciences, Psychedelics Genetic Test Kit Now Available for Sale in US

Vancouver, British Columbia–(Newsfile Corp. – June 10, 2021) – Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF)…

Entheon Biomedical Corp. Launches HaluGen’s Psychedelics Genetic Test

Vancouver, British Columbia–(Newsfile Corp. – April 6, 2021) – Entheon Biomedical Corp. (CSE: ENBI) (FSE: 1XU1)…